Analysed REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) News Sources
Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
31-08-2026
yahoo.com
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
01-09-2026
yahoo.com
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
01-09-2026
yahoo.com
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
30-07-2026
yahoo.com
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
02-06-2026
yahoo.com
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
08-06-2026
yahoo.com
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
31-08-2026
yahoo.com
What is the current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?
The current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is $0.5751.
REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) absolute price change since previous trading day?
The absolute price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is $-0.0388.
REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) percentage price change since previous trading day?
The percentage price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is -6.3202%.
What is the most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?
The most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?
The most recent sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is .
SEC-8K** Filing Available For REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.